Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.

MLA

Alawode, D. O. T., et al. “Transitioning from Cerebrospinal Fluid to Blood Tests to Facilitate Diagnosis and Disease Monitoring in Alzheimer’s Disease.” Journal of Internal Medicine, vol. 290, no. 3, Sept. 2021, pp. 583–601. EBSCOhost, https://doi.org/10.1111/joim.13332.

APA

Alawode, D. O. T., Heslegrave, A. J., Ashton, N. J., Karikari, T. K., Simrén, J., Montoliu, G. L., Pannee, J., O, C. A., Weston, P. S. J., Lantero, R. J., Keshavan, A., Snellman, A., Gobom, J., Paterson, R. W., Schott, J. M., Blennow, K., Fox, N. C., & Zetterberg, H. (2021). Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer’s disease. Journal of Internal Medicine, 290(3), 583–601. https://doi.org/10.1111/joim.13332

Chicago

Alawode, D. O. T., A. J. Heslegrave, N. J. Ashton, T. K. Karikari, J. Simrén, Gaya, L. Montoliu, J. Pannee, et al. 2021. “Transitioning from Cerebrospinal Fluid to Blood Tests to Facilitate Diagnosis and Disease Monitoring in Alzheimer’s Disease.” Journal of Internal Medicine 290 (3): 583–601. doi:10.1111/joim.13332.